Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Chelsea Therapeutics International Ltd.    

 SummaryNewsCalendarCompanyFinancials 
Company
Chelsea Therapeutics International Ltd. acquires, develops and commercializes innovative products for the treatment of a variety of human diseases.The company was founded by Simon C. Pedder on June 17, 2005 and is headquartered in Charlotte, NC. 
Sector
Biotechnology & Medical Research
Calendar

- No events available -

More about the company
Latest news on CHELSEA THERAPEUTICS INTER
2014 Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at Intern..
2014 CHELSEA THERAPEUTICS : Shareholder Alert: Former SEC Attorney Willie Briscoe and..
2014 CHELSEA THERAPEUTICS : SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investi..
2014 CHELSEA THERAPEUTICS : INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investiga..
2014 CHELSEA THERAPEUTICS : Newman Ferrara LLP : Announces Investigation of Chelsea T..
2014 CHELSEA THERAPEUTICS : SHAREHOLDER ALERT: Brower Piven Announces the Investigati..
2014 CHELSEA THERAPEUTICS : Law Firm Kirby McInerney LLP Investigating Potential Clai..
2014 CHELSEA THERAPEUTICS : SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Inves..
2014 CHELSEA THERAPEUTICS : INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investiga..
2014 Chelsea Therapeutics Joins NORD in Promoting Awareness for Rare Disease Day
More news
Sector news : Bio Therapeutic Drugs
08/17 FDA expands use of AstraZeneca/Merck ovarian cancer drug
08/15 Three CEOs resign from Trump council over Charlottesville
08/14DJHot Stocks to Watch in the U.S. and Canada
08/11DJGILEAD SCIENCES : England's NHS Turns to Clinical Trial to Make Cheaper HIV Drug..
08/11DJGILEAD SCIENCES : England's NHS Turns to Clinical Trial to Make Cheaper HIV Drug..
More sector news : Bio Therapeutic Drugs
Income Statement Evolution
Managers
NameTitle
Staffan Schüberg President & Director
Julie Hakim Secretary, Treasurer & Director
Sector and Competitors
1st jan.Capitalization (M$)
CHELSEA THERAPEUTICS INTERNATIONAL LTD.0
AMGEN14.42%122 067
CELGENE CORPORATION10.28%99 867
GILEAD SCIENCES0.70%94 170
REGENERON PHARMACEUTICALS26.41%50 145
VERTEX PHARMACEUTICALS101.07%37 346